BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

268 related articles for article (PubMed ID: 31575852)

  • 21. Flow cytometric predictive scoring systems for common fusions ETV6/RUNX1, BCR/ABL1, TCF3/PBX1 and rearrangements of the KMT2A gene, proposed for the initial cytogenetic approach in cases of B-acute lymphoblastic leukemia.
    Tsagarakis NJ; Papadhimitriou SI; Pavlidis D; Marinakis T; Kostopoulos IV; Stiakaki E; Polychronopoulou S; Paterakis G
    Int J Lab Hematol; 2019 Jun; 41(3):364-372. PubMed ID: 30730614
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Impact of TCF3 rearrangement on CNS relapse in egyptian pediatric acute lymphoblastic leukemia.
    ElGendi HM; Abdelmaksoud AA; Eissa DG; Abusikkien SA
    Pediatr Hematol Oncol; 2014 Oct; 31(7):638-46. PubMed ID: 25116187
    [TBL] [Abstract][Full Text] [Related]  

  • 23.
    Naskar S; Paul T; Kulkarni JD; Anand KC; Divya V; Rambhojun HD
    Leuk Lymphoma; 2024 Jun; 65(6):852-856. PubMed ID: 38407197
    [No Abstract]   [Full Text] [Related]  

  • 24. CircRNAome of Childhood Acute Lymphoblastic Leukemia: Deciphering Subtype-Specific Expression Profiles and Involvement in
    Gutierrez-Camino A; Caron M; Richer C; Fuchs C; Illarregi U; Poncelet L; St-Onge P; Bataille AR; Tremblay-Dauphinais P; Lopez-Lopez E; Camos M; Ramirez-Orellana M; Astigarraga I; Lécuyer É; Bourque G; Martin-Guerrero I; Sinnett D
    Int J Mol Sci; 2024 Jan; 25(3):. PubMed ID: 38338754
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Wnt5a and ROR1 activate non-canonical Wnt signaling via RhoA in TCF3-PBX1 acute lymphoblastic leukemia and highlight new treatment strategies via Bcl-2 co-targeting.
    Karvonen H; Perttilä R; Niininen W; Hautanen V; Barker H; Murumägi A; Heckman CA; Ungureanu D
    Oncogene; 2019 Apr; 38(17):3288-3300. PubMed ID: 30631148
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Prognostic impact of t(1;19)/ TCF3-PBX1 in childhood acute lymphoblastic leukemia in the context of Berlin-Frankfurt-Münster-based protocols.
    Felice MS; Gallego MS; Alonso CN; Alfaro EM; Guitter MR; Bernasconi AR; Rubio PL; Zubizarreta PA; Rossi JG
    Leuk Lymphoma; 2011 Jul; 52(7):1215-21. PubMed ID: 21534874
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Comprehensive chromosomal aberrations in a case of a patient with TCF3-HLF-positive BCP-ALL.
    Lejman M; Włodarczyk M; Zawitkowska J; Kowalczyk JR
    BMC Med Genomics; 2020 Apr; 13(1):58. PubMed ID: 32245383
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Systematic application of fluorescence in situ hybridization and immunophenotype profile for the identification of ZNF384 gene rearrangements in B cell acute lymphoblastic leukemia.
    Janet NB; Kulkarni U; Arun AK; Bensega B; Devasia AJ; Korula A; Abraham A; George B; Mathews V; Balasubramanian P
    Int J Lab Hematol; 2021 Aug; 43(4):658-663. PubMed ID: 33988307
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Excellent outcome of acute lymphoblastic leukaemia with TCF3-PBX1 rearrangement in Hong Kong.
    Lin A; Cheng FWT; Chiang AKS; Luk CW; Li RCH; Ling ASC; Cheuk DKL; Chang KO; Ku D; Lee V; Ha SY; Li CK
    Pediatr Blood Cancer; 2018 Dec; 65(12):e27346. PubMed ID: 30051646
    [TBL] [Abstract][Full Text] [Related]  

  • 30. SVAtools for junction detection of genome-wide chromosomal rearrangements by mate-pair sequencing (MPseq).
    Johnson SH; Smadbeck JB; Smoley SA; Gaitatzes A; Murphy SJ; Harris FR; Drucker TM; Zenka RM; Pitel BA; Rowsey RA; Hoppman NL; Aypar U; Sukov WR; Jenkins RB; Feldman AL; Kearney HM; Vasmatzis G
    Cancer Genet; 2018 Feb; 221():1-18. PubMed ID: 29405991
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Utilizing next-generation sequencing to characterize a case of acute myeloid leukemia with t(4;12)(q12;p13) in the absence of ETV6/CHIC2 and ETV6/PDGFRA gene fusions.
    Koleilat A; McGarrah PW; Olteanu H; Van Dyke DL; Smadbeck JB; Johnson SH; Vasmatzis G; Hoppman NL; Xu X; Ketterling RP; Greipp PT; Baughn LB; Patnaik MS; Peterson JF
    Cancer Genet; 2022 Jan; 260-261():1-5. PubMed ID: 34781094
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Long-Term Results of the Risk-Stratified Treatment of TCF3-PBX1-Positive Pediatric Acute Lymphoblastic Leukemia in China.
    Wang Y; Xue YJ; Lu AD; Jia YP; Zuo YX; Zhang LP
    Clin Lymphoma Myeloma Leuk; 2021 Feb; 21(2):e137-e144. PubMed ID: 33221150
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Mate pair sequencing improves detection of genomic abnormalities in acute myeloid leukemia.
    Aypar U; Smoley SA; Pitel BA; Pearce KE; Zenka RM; Vasmatzis G; Johnson SH; Smadbeck JB; Peterson JF; Geiersbach KB; Van Dyke DL; Thorland EC; Jenkins RB; Ketterling RP; Greipp PT; Kearney HM; Hoppman NL; Baughn LB
    Eur J Haematol; 2019 Jan; 102(1):87-96. PubMed ID: 30270457
    [TBL] [Abstract][Full Text] [Related]  

  • 34. KMT2A (MLL) rearrangements observed in pediatric/young adult T-lymphoblastic leukemia/lymphoma: A 10-year review from a single cytogenetic laboratory.
    Peterson JF; Baughn LB; Pearce KE; Williamson CM; Benevides Demasi JC; Olson RM; Goble TA; Meyer RG; Greipp PT; Ketterling RP
    Genes Chromosomes Cancer; 2018 Nov; 57(11):541-546. PubMed ID: 30203571
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Childhood pre-B cell acute lymphoblastic leukemia with translocation t(1;19)(q21.1;p13.3) and two additional chromosomal aberrations involving chromosomes 1, 6, and 13: a case report.
    Wafa A; As'sad M; Liehr T; Aljapawe A; Al Achkar W
    J Med Case Rep; 2017 Apr; 11(1):94. PubMed ID: 28385156
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Clinical features and prognostic impact of TCF3-PBX1 in childhood acute lymphoblastic leukemia: A single-center retrospective study of 837 patients from China.
    Jia M; Hu BF; Xu XJ; Zhang JY; Li SS; Tang YM
    Curr Probl Cancer; 2021 Dec; 45(6):100758. PubMed ID: 34034913
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Multiple heterogeneous bone invasions of B lymphoblastic lymphoma with the TCF3/PBX1 fusion gene: a case report.
    Okura E; Saito S; Natsume T; Morita D; Tanaka M; Kiyokawa N; Nakazawa Y
    Int J Hematol; 2020 Feb; 111(2):163-165. PubMed ID: 31828595
    [No Abstract]   [Full Text] [Related]  

  • 38. Clinical features and prognostic significance of TCF3-PBX1 fusion gene in Chinese children with acute lymphoblastic leukemia by using a modified ALL-BFM-95 protocol.
    Pang L; Liang Y; Pan J; Wang JR; Chai YH; Zhao WL
    Pediatr Hematol Oncol; 2015 Apr; 32(3):173-81. PubMed ID: 25551271
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Genome-Wide Association Study of Susceptibility Loci for TCF3-PBX1 Acute Lymphoblastic Leukemia in Children.
    Lee SHR; Qian M; Yang W; Diedrich JD; Raetz E; Yang W; Dong Q; Devidas M; Pei D; Yeoh A; Cheng C; Pui CH; Evans WE; Mullighan CG; Hunger SP; Savic D; Relling MV; Loh ML; Yang JJ
    J Natl Cancer Inst; 2021 Jul; 113(7):933-937. PubMed ID: 32882024
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Outcome of TCF3-PBX1 positive pediatric acute lymphoblastic leukemia patients in Japan: a collaborative study of Japan Association of Childhood Leukemia Study (JACLS) and Children's Cancer and Leukemia Study Group (CCLSG).
    Asai D; Imamura T; Yamashita Y; Suenobu S; Moriya-Saito A; Hasegawa D; Deguchi T; Hashii Y; Endo M; Hatakeyama N; Kawasaki H; Hori H; Horibe K; Yumura-Yagi K; Hara J; Watanabe A; Kikuta A; Oda M; Sato A;
    Cancer Med; 2014 Jun; 3(3):623-31. PubMed ID: 24578304
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.